Gilead Sciences (GILD) Debt to Equity (2009 - 2026)
Gilead Sciences (GILD) posted Debt to Equity of $0.94 for Q1 2026, down 14.15% quarter-over-quarter from $1.1 in Q4 2025, and down 27.9% year-on-year from $1.31 in Q1 2025.
Gilead Sciences (GILD) Debt to Equity (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Debt to Equity for 18 consecutive years, with $0.94 the latest figure, recorded in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.94, down 27.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.94 (down 27.9% YoY), and the FY2025 annual result was $1.1, down 20.86% from the prior year.
- Debt to Equity was $0.94 for Q1 2026 at Gilead Sciences, down from $1.1 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.44 in Q1 2024 and troughed at $0.94 in Q1 2026.
- Average Debt to Equity over 5 years is $1.22, with a median of $1.21 recorded in 2023.
- Year-over-year, Debt to Equity gained 26.36% in 2024 and declined 27.9% in 2026.
- Over 5 years, Debt to Equity stood at $1.19 in 2022, then dropped by 7.67% to $1.1 in 2023, then increased by 26.36% to $1.39 in 2024, then retreated by 20.86% to $1.1 in 2025, then decreased by 14.15% to $0.94 in 2026.
- Per Business Quant data, the three most recent Debt to Equity figures were $0.94 in Q1 2026, $1.1 in Q4 2025, and $1.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.39 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.68 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.70 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.72 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 1.10 |
| Sep 30, 2025 | 1.16 |
| Jun 30, 2025 | 1.27 |
| Mar 31, 2025 | 1.31 |
| Dec 31, 2024 | 1.39 |
| Sep 30, 2024 | 1.26 |
| Jun 30, 2024 | 1.28 |
| Mar 31, 2024 | 1.44 |
| Dec 31, 2023 | 1.10 |
| Sep 30, 2023 | 1.12 |
| Jun 30, 2023 | 1.20 |
| Mar 31, 2023 | 1.21 |
| Dec 31, 2022 | 1.19 |
| Sep 30, 2022 | 1.20 |
| Jun 30, 2022 | 1.30 |
| Mar 31, 2022 | 1.32 |
| Dec 31, 2021 | 1.27 |
| Sep 30, 2021 | 1.29 |
| Jun 30, 2021 | 1.53 |